M&A

Bioclinica Acquires MDDX Research & Informatics Combining Advanced Image Management Cloud Technology with Its Scientific and Medical Imaging Leadership

November 7, 2017

Best-in-class solution ensures sponsors and CROs have global access to efficient, accurate, and scalable medical imaging to drive better data and outcomes DOYLESTOWN, Pa., Nov. 6, 2017 – Bioclinica®, the world-leading provider of scientific-enabled Medical Imaging, eHealth, and patient-centric solutions supporting clinical research, today announces it has acquired Silicon Valley-based MDDX Research & Informatics, adding […]

Chesapeake IRB and Schulman IRB Merge to Establish Premier Independent Institutional Review Board for Research

November 7, 2017

Columbia, Md., and Cincinnati, Ohio, November 7, 2017 (Business Wire) – Chesapeake IRB and Schulman IRB, the research industry’s two most respected institutional review boards (IRBs), have combined to create Advarra, the premier provider of IRB, institutional biosafety committee (IBC) and research compliance services in North America. The new organization will leverage mutual strengths in […]

Sanofi Pulls Back from Voyager Gene Therapy Pact in Parkinson’s

November 2, 2017

A key study for Voyager Therapeutics and its experimental gene therapy for Parkinson’s disease will have to move ahead without help from pharmaceutical giant Sanofi, which has walked away from the deal.   Global rights to Parkinson’s treatment VY-AADC01 are now squarely in the hands of Cambridge, MA-based Voyager (NASDAQ: VYGR). Two years ago, the […]

Neos Therapeutics to Consider Other Offers After PDL Snub

November 2, 2017

Oct 31 (Reuters) – U.S. drugmaker Neos Therapeutics Inc, which this week rejected a fourth takeover offer by PDL Biopharma Inc, will consider offers from other potential buyers, according to people familiar with the matter.   Neos, a developer of attention deficit disorder treatments, rejected, as inadequate, a nearly $300 million all-cash bid from PDL […]

Almac Group Announces Acquisition of BioClin Laboratories

November 1, 2017

Craigavon, N.I., 01 November 2017 – Almac Group, the global contract development and manufacturing organisation, today announced the acquisition of 100% shares of BioClin Laboratories, an independent and privately owned organisation based in Athlone, Ireland. Established in 2002 and located in Garrycastle, just two hours away from Almac Group’s Headquarters in Northern Ireland, BioClin is […]

NuLife Announces Planned Merger with Ensysce Biosciences

October 31, 2017

NEWPORT BEACH, CA–(Marketwired – October 31, 2017) – NuLife Sciences (OTCQB: NULF) today announced the signing of a letter of intent to undertake a formal merger with Ensysce Biosciences of San Diego, California, a clinical stage company with delivery platforms for both small and large molecule therapies. Ensysce’s BIO-MD™ is a prodrug delivery platform that […]

Advanced Accelerator Applications Announces $3.9 Billion All Cash Proposed Tender Offer by Novartis

October 30, 2017

SAINT-GENIS-POUILLY, France, Oct. 30, 2017 (GLOBE NEWSWIRE) — Advanced Accelerator Applications S.A. (NASDAQ:AAAP) (AAA or the Company), a leader in nuclear medicine theragnostics, today announced that it has entered into a Memorandum of Understanding with Novartis, pursuant to which Novartis proposes to make a cash tender offer to acquire all the outstanding shares of AAA, […]

Novartis announces the planned acquisition of Advanced Accelerator Applications to strengthen oncology portfolio

October 30, 2017

Basel, October 30, 2017 – Novartis announced today, that it has entered a memorandum of understanding with Advanced Accelerator Applications (AAA) under which Novartis intends to commence a tender offer for 100% of the share capital of AAA subject to certain conditions. Advanced Accelerator Applications (NASDAQ:AAAP) is a radiopharmaceutical company that develops, produces and commercializes […]

Aviragen Therapeutics and Vaxart Enter into Merger Agreement

October 30, 2017

ATLANTA and SOUTH SAN FRANCISCO, Calif., Oct. 30, 2017 (GLOBE NEWSWIRE) — Aviragen Therapeutics, Inc. (NASDAQ:AVIR), a company focused on the discovery and development of direct-acting antivirals to treat infections that have limited therapeutic options, and Vaxart, Inc., a privately-held, clinical-stage company focused on developing oral recombinant vaccines based on its proprietary delivery platform that […]

Factory CRO Acquires MileStone Research Organization, Builds North American Presence

October 26, 2017

Bilthoven, Netherlands, Oct. 26, 2017 (Business Wire) — Factory CRO, a leading global contract research organization focused on medical devices and IVDs, has announced the acquisition of MileStone Research Organization. MileStone, located in San Diego, specializes in clinical research and reimbursement solutions for the medical device and biologics industries. “The merger with MileStone is an […]

Vir Biotechnology Builds Pipeline, Capabilities, and Lays Out Strategy to Address Serious Infectious Diseases

October 18, 2017

SAN FRANCISCO–(BUSINESS WIRE)–Vir Biotechnology, Inc. today announced agreements with Humabs BioMed SA, Alnylam Pharmaceuticals, Inc. (NASDAQ:ALYN), and Visterra, Inc., as well as four leading academic research institutions. Together with the company’s internal research and development capabilities, these achievements provide the foundation on which Vir will pursue its mission of transforming the care of people with […]

Neothetics, Inc. and Evofem Biosciences, Inc. Announce Merger Agreement to Create Women’s Health Company

October 17, 2017

SAN DIEGO, Oct. 17, 2017 (GLOBE NEWSWIRE) — Neothetics, Inc. (NASDAQ:NEOT) and Evofem Biosciences, Inc. today announced they have entered into a definitive agreement under which privately-held Evofem Biosciences will merge with a wholly-owned subsidiary of Neothetics in an all-stock transaction. The merger will position the combined company with an opportunity to become a leading […]

Neovia S.A.S. to Acquire Epicore BioNetworks Inc.

October 17, 2017

EASTAMPTON, New Jersey, October 16, 2017 /PRNewswire/ —   Epicore BioNetworks Inc.(“Epicore”) (TSXV: EBN) and Neovia S.A.S. (“Neovia”) jointly announced today that Epicore and Neovia have entered into an arrangement agreement dated October 13, 2017 (Arrangement Agreement”) pursuant to which Neovia will acquire all of the issued and outstanding shares of Epicore on a fully-diluted […]

Combination Creates Diversified Pharmaceutical Company with 5th Largest Generics Business in the United States

October 17, 2017

BRIDGEWATER, N.J. and HAYWARD, Calif., Oct. 17, 2017 /PRNewswire/ — Amneal Pharmaceuticals LLC and Impax Laboratories, Inc. (NASDAQ: IPXL) today announced that they have entered into a definitive business combination in an all-stock transaction. As a result of the transaction, Amneal Holdings members will own approximately 75% and Impax shareholders will own approximately 25% of […]

Consortium Led By GL Capital Completes Acquisition Of SciClone

October 16, 2017

FOSTER CITY, Calif., Oct. 13, 2017 /PRNewswire/ — SciClone Pharmaceuticals, Inc. (NASDAQ: SCLN) (the “Company” or “SciClone”) and a consortium consisting of entities affiliated with GL Capital Management GP Limited (“GL Capital”), Bank of China Group Investment Limited (“BOCGI”), CDH Investments, Ascendent Capital Partners and Boying (collectively, the “Buyer Consortium”) today announced completion of the […]

ELSALYS BIOTECH acquires from JAZZ PHARMACEUTICALS the worldwide rights of LEUKOTAC®

October 13, 2017

Lyon, FRANCE, October 12, 2017, ELSALYS BIOTECH, a new player in immuno-oncology, has acquired from JAZZ PHARMACEUTICALS the development and commercialization rights of LEUKOTAC®(inolimomab), a monoclonal antibody that has recently demonstrated its clinical superiority in the treatment of Steroid-Resistant acute Graft-versus-Host Disease (steroid-resistant aGvHD), an orphan disease with very poor prognosis. GvHD is the main […]

Inotek Pharmaceuticals Announces Filing of Preliminary Proxy Statement for Proposed Merger with Clinical-stage Gene Therapy Company, Rocket Pharmaceuticals

October 13, 2017

LEXINGTON, Mass. & NEW YORK, NY–(BUSINESS WIRE)–Inotek Pharmaceuticals Corporation (NASDAQ: ITEK) today announced the filing with the US Securities and Exchange Commission (SEC) of the Company’s preliminary proxy statement in connection with the previously announced proposed combination of Inotek Pharmaceuticals and Rocket Pharmaceuticals, a leading US-based multi-platform gene therapy company (the Merger).   “We believe […]

Express Scripts to Acquire eviCore healthcare; Accelerates Company’s Shift to Patient Benefit Management

October 11, 2017

LOUIS and BLUFFTON, S.C., Oct. 10, 2017 /PRNewswire/ — Express Scripts Holding Company (NASDAQ: ESRX) today announced that it has reached an agreement to acquire privately-held eviCore healthcare, the industry leader in evidence-based medical benefit management services, for $3.6 billion. Combining Express Scripts’ leading pharmacy benefit management offering and eviCore’s highly complementary medical benefits management […]

Kitov Boosts Ownership in TyrNovo and Oncology Platform Through Exchange of Shares for Stock

October 9, 2017

TEL AVIV, Israel, Oct. 6, 2017 /PRNewswire/ — Kitov Pharmaceuticals Holdings Ltd. (NASDAQ: KTOV, TASE: KTOV), (“Kitov” or “the Company”) an innovative biopharmaceutical company, announced today the acquisition of an additional 27% stake in TyrNovo Ltd., a privately- held developer of novel small molecules in the oncology therapeutic field, from unaffiliated minority shareholders. As announced […]

Harmony Biosciences Acquires US Rights to Pitolisant From Bioprojet; Raises $270 Million in Equity Financing

October 6, 2017

PARIS, October 6, 2017 /PRNewswire/ —     Funding will accelerate development and registration of a novel drug for adults suffering from narcolepsy   Biopharmaceutical company Harmony Biosciences, LLC (Harmony), a member of the Paragon Biosciences (Paragon) corporate family, today announced it has acquired the exclusive US right to develop, register and market the drug […]

Ligand to Acquire Crystal Bioscience, the Leader in Chicken-derived Fully-human Antibody Generation, for $25 Million in Cash plus Additional Potential Payments

October 5, 2017

SAN DIEGO & EMERYVILLE, Calif.–(BUSINESS WIRE)–Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) and Crystal Bioscience, Inc. (Crystal) announce the signing of a merger agreement whereby Ligand will acquire Crystal, a leader in avian genetics and the generation of fully-human therapeutic antibodies. Under the terms of the agreement, Ligand will pay Crystal shareholders $25 million in cash at […]

Aerie Pharmaceuticals Announces Drug Delivery Asset Acquisition to Further Advance Its Retinal Disease Program

October 5, 2017

IRVINE, Calif.–(BUSINESS WIRE)–Aerie Pharmaceuticals, Inc. (NASDAQ:AERI) (Aerie or the Company), a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of first-in-class therapies for the treatment of patients with glaucoma and other diseases of the eye, today announced that it has acquired from Envisia Therapeutics Inc. (Envisia) the rights to use PRINT® technology in […]

MiMedx Completes Divestiture Of Its Stability Biologics Subsidiary

October 3, 2017

MARIETTA, Ga., Oct. 2, 2017 /PRNewswire/ — MiMedx Group, Inc. (NASDAQ: MDXG), the leading biopharmaceutical company developing and marketing regenerative and therapeutic biologics utilizing human placental tissue allografts and patent-protected processes for multiple sectors of healthcare, announced today that it has completed the previously communicated divestiture of the Company’s subsidiary, Stability Biologics LLC (f/k/a Stability […]

Abbott Acquisition of Alere Set to Close on October 3, 2017

October 2, 2017

WALTHAM, Mass., Sept. 29, 2017 /PRNewswire/ — Alere Inc. (NYSE: ALR) announced today that Abbott’s acquisition of Alere is intended to close on October 3, 2017. The announcement follows receipt of all regulatory clearances necessary for closing.   Alere intends to request that the New York Stock Exchange cease trading of Alere’s common stock before […]

REGENXBIO Responds to Notification of a Superior Proposal Under Its Merger Agreement With Dimension Therapeutics

October 2, 2017

ROCKVILLE, Md., Oct. 02, 2017 (GLOBE NEWSWIRE) — REGENXBIO Inc. (Nasdaq:RGNX) today announced that Dimension Therapeutics, Inc. (Nasdaq:DMTX) notified REGENXBIO that it has determined that it has received a “superior proposal” as defined in the merger agreement under which REGENXBIO would have acquired Dimension in an all-stock transaction for an implied value of approximately $3.41 […]

Mallinckrodt Completes Acquisition of InfaCare Pharmaceutical Corporation and Stannsoporfin, its Proprietary Therapy in Late-Stage Development for Newborns at Risk for Severe Jaundice

September 26, 2017

STAINES-UPON-THAMES, United Kingdom, Sept. 25, 2017 /PRNewswire/ — Mallinckrodt plc (NYSE: MNK), a leading global specialty pharmaceutical company, today announced it closed the acquisition of InfaCare Pharmaceutical Corporation, a privately held specialty pharmaceutical company focused on development and commercialization of proprietary pharmaceuticals for neonatal and pediatric patient populations. If approved, InfaCare’s developmental product stannsoporfin is […]

Galen US Inc. Acquires First Inhaled Therapy Approved to Treat Agitation Associated with Schizophrenia and Bipolar I Disorder, Announces Revised Labeling

September 26, 2017

SOUDERTON, Pa.–(BUSINESS WIRE)–Galen US Inc. today announced its acquisition of the US commercial rights to ADASUVE®, an orally inhaled form of the typical antipsychotic loxapine, from Alexza Pharmaceuticals, Inc. ADASUVE is the first and only FDA-approved inhaled therapy for the acute treatment of agitation associated with schizophrenia or bipolar I disorder in adults.1 ADASUVE offers […]

Konica Minolta Accelerates Expansion of Precision Medicine Business Through Acquisition of US-based Pharmaceutical Research Company, Invicro

September 25, 2017

TOKYO & BOSTON–(BUSINESS WIRE)–Konica Minolta, Inc. (“Konica Minolta”) (TOKYO: 4902; ISIN: JP3300600008) and Boston-based Invicro LLC (“Invicro”) today announced that they have concluded an agreement whereby Konica Minolta will acquire Invicro, a leading provider of imaging services and software for research and drug development.   “We are a quantitative biomarker company. Whether in medical imaging […]

FEEDBACK